Cargando…

The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma

The C-reactive protein/albumin (CRP/Alb) ratio has been recently identified as a prognostic factor in various cancers, whereas its role remains unclear in metastatic nasopharyngeal carcinoma (NPC). The current study retrospectively analyzed 148 patients with metastatic NPC who underwent cisplatin-ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Peng, Chen, Cui, Xia, Yi, Bi, Xiwen, Liu, Panpan, Zhang, Fei, Yang, Hang, An, Xin, Jiang, Wenqi, Wang, Fenghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476879/ https://www.ncbi.nlm.nih.gov/pubmed/28676731 http://dx.doi.org/10.1155/2017/6570808

Ejemplares similares

Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma
por: Nie, Man, et al.
Publicado: (2017)

The C-reactive Protein/Albumin Ratio Is an independent Prognostic Factor for Overall Survival in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy
por: Tao, Chang-Juan, et al.
Publicado: (2016)

Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients
por: Hang, Junjie, et al.
Publicado: (2017)

The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China
por: Sun, Peng, et al.
Publicado: (2016)

C-Reactive Protein/Albumin Ratio (CAR) as a Prognostic Factor in Patients with Non-Metastatic Nasopharyngeal Carcinoma
por: He, ShaSha, et al.
Publicado: (2016)

The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer
por: Wu, Mengwan, et al.
Publicado: (2016)

Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma
por: Sun, Hao, et al.
Publicado: (2023)

Pretreatment C-reactive protein/albumin ratio for predicting overall survival in pancreatic cancer: A meta-analysis
por: Zang, Ye, et al.
Publicado: (2020)

The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis
por: Gao, Nan, et al.
Publicado: (2018)

Predictive Value of C-Reactive Protein-to-Albumin Ratio for Neonatal Sepsis
por: Li, Tiewei, et al.
Publicado: (2021)

Exploration and Validation of C-Reactive Protein/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma
por: Zhang, Yuan, et al.
Publicado: (2016)

Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer
por: Zhou, Ting, et al.
Publicado: (2015)

Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors
por: He, Xia, et al.
Publicado: (2018)

Predictor parameters for poor prognosis in patients with sudden sensorineural hearing loss: fibrinogen to albumin ratio vs C-reactive protein to albumin ratio
por: Cayir, Serkan, et al.
Publicado: (2020)

The C-Reactive Protein/Albumin Ratio as a Predictor of Mortality in Critically Ill Patients
por: Park, Ji Eun, et al.
Publicado: (2018)

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study
por: Hong, Shaodong, et al.
Publicado: (2021)

Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy
por: Koh, Young W., et al.
Publicado: (2017)

Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature
por: Yang, Xiaodi, et al.
Publicado: (2018)

Interleukin-6 and C-reactive protein/albumin ratio as predictors of COVID-19 severity and mortality
por: El-Shabrawy, Mohamed, et al.
Publicado: (2021)

The Glasgow Prognostic Score Predicts Poor Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma
por: Chen, Cui, et al.
Publicado: (2014)

Nomogram Based on Lactate Dehydrogenase-to-Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for Predicting Survival in Nasopharyngeal Carcinoma
por: Peng, Ru-Rong, et al.
Publicado: (2021)

Association between C-reactive protein-albumin ratio and overall survival in Parkinson's disease using publicly available data: A retrospective cohort study
por: Gao, Mengqi, et al.
Publicado: (2023)

Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma
por: Huang, Yan, et al.
Publicado: (2016)

High C-reactive protein/albumin ratio predicts unfavorable distant metastasis-free survival in nasopharyngeal carcinoma: a propensity score-matched analysis
por: Wang, Yan, et al.
Publicado: (2018)

A Novel Predictor Parameter for Active Recurrent Aphthous Stomatitis: C-Reactive Protein to Albumin Ratio
por: Kayabasi, Serkan, et al.
Publicado: (2019)

The Ratio of C-Reactive Protein to Albumin Is an Independent Predictor of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas
por: Serafini, Simone, et al.
Publicado: (2021)

C-reactive protein–to–albumin ratio is a predictor of 1-year mortality following liver transplantation
por: Kim, Kyoung-Sun, et al.
Publicado: (2022)

Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma
por: Liao, Wenjun, et al.
Publicado: (2021)

Establishment and Validation of Nomogram Based on Combination of Pretreatment C-Reactive Protein/Albumin Ratio–EBV DNA Grade in Nasopharyngeal Carcinoma Patients Who Received Concurrent Chemoradiotherapy
por: Huang, Zhang-Zan, et al.
Publicado: (2021)

Comparison Efficacy and Safety of Gemcitabine plus Cisplatin and 5-Fluorouracil plus Cisplatin for Metastatic Nasopharyngeal Carcinoma: A Meta-Analysis and Systematic Review
por: Yan, Le, et al.
Publicado: (2022)

Inflammatory Markers as Predictors of Atrial Fibrillation Recurrence: Exploring the C-Reactive Protein to Albumin Ratio in Cryoablation Patients
por: Ozkan, Eyup, et al.
Publicado: (2023)

Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancer
por: Sun, Xiaowei, et al.
Publicado: (2016)

Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholangiocarcinoma patients after surgery
por: Xiong, Jian-Ping, et al.
Publicado: (2019)

Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival
por: Sun, Lejia, et al.
Publicado: (2021)

C-Reactive Protein/Albumin and Neutrophil/Albumin Ratios as Novel Inflammatory Markers in Patients with Schizophrenia
por: Balcioglu, Yasin Hasan, et al.
Publicado: (2020)

The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis
por: Cui, Xinhua, et al.
Publicado: (2020)

The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
por: Shibutani, Masatsune, et al.
Publicado: (2016)

Immunological predictors of overall survival in treatment naïve metastatic pancreatic cancer patients
por: Farren, Matthew R, et al.
Publicado: (2015)

Prognostic value of C-reactive protein to albumin ratio in metastatic colorectal cancer: A systematic review and meta-analysis
por: Pan, Yan, et al.
Publicado: (2021)

Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma
por: Li, Wanwan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3l8j68e2et37momvsq1jaqd2k8